Back

Rivaroxaban plus aspirin in patients with and without heart failure and chronic coronary or peripheral artery disease: the COMPASS trial

28 May 2018 (17:00 - 17:10)
Organised by:
Congress Presentation Part of: Late breaking trial IV - Registries Revascularisation HFA Premium Access Heart Failure 2018

About the speaker

Photo
Professor Kelley Branch

University of Washington, Seattle (United States of America)

11 More presentations in this session

Presentation thumbnail
Association between sacubitril/valsartan initiation and health status outcomes in heart failure with reduced ejection fraction: findings from the CHAMP-HF registry
Doctor Y. Khariton (Kansas City, US)
Slides Video
Presentation thumbnail
Discussion - Sacubitril/Valsartan initiation and health status outcomes in HFrEF
Video
Presentation thumbnail
Subtle ventricular dysfunction outperforms other risk markers in patients with coronary artery disease
Professor D. Kotecha (Birmingham, GB)
Slides Video
Presentation thumbnail
Discussion - ARM-CAD
Video
Presentation thumbnail
Discussion - COMPASS CHF
Video

Access the full session

Session thumbnail
Late breaking trial IV - Registries

The Event

Event poster

Heart Failure 2018

28 May 2018 17:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources